These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12580416)

  • 1. Development of an economic miniantibody production process for the purification of Protein C (anti-coagulant/anti-thrombotic).
    Korah LK; Ahn DG; Kang KA
    Adv Exp Med Biol; 2003; 510():127-31. PubMed ID: 12580416
    [No Abstract]   [Full Text] [Related]  

  • 2. Preliminary study for the protein C purification using mini-antibodies produced from recombinant E. coli.
    Korah LK; Kang KA
    Adv Exp Med Biol; 2003; 540():171-6. PubMed ID: 15174617
    [No Abstract]   [Full Text] [Related]  

  • 3. Separation of human protein C from components of transgenic milk using immobilized metal affinity chromatography.
    Dave AS; Bruley DF
    Adv Exp Med Biol; 1999; 471():639-47. PubMed ID: 10659198
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost effective metal affinity chromatography for protein C specific, mini-antibody purification.
    Rezania S; Ahn DG; Kang KA
    Adv Exp Med Biol; 2006; 578():49-54. PubMed ID: 16927669
    [No Abstract]   [Full Text] [Related]  

  • 5. New biological concepts on coagulation inhibitors.
    Sala N; Fontcuberta J; Rutllant ML
    Intensive Care Med; 1993; 19 Suppl 1():S3-7. PubMed ID: 8227737
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-Coagulant and Anti-Thrombotic Properties of Blacklip Abalone (Haliotis rubra): In Vitro and Animal Studies.
    Suleria HAR; Masci PP; Zhao KN; Addepalli R; Chen W; Osborne SA; Gobe GC
    Mar Drugs; 2017 Aug; 15(8):. PubMed ID: 28777290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Process scale-up studies for protein C separation using IMAC.
    Wu H; Bruley DF
    Adv Exp Med Biol; 2005; 566():243-8. PubMed ID: 16594158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Resistance to activated protein C. A common genetic risk factor in venous thrombosis].
    Berntorp E; Svensson P; Zöller B; Lethagen S; Dahlbäck B
    Lakartidningen; 1995 Sep; 92(39):3587-90. PubMed ID: 7564599
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro anti-thrombotic and anti-coagulant properties of blacklip abalone (Haliotis rubra) viscera hydrolysate.
    Suleria HAR; Masci PP; Addepalli R; Chen W; Gobe GC; Osborne SA
    Anal Bioanal Chem; 2017 Jul; 409(17):4195-4205. PubMed ID: 28493022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Can we still afford progress in intensive care medicine? Re: the article from DMW 1-2/2004].
    Kalenka A
    Dtsch Med Wochenschr; 2004 Jul; 129(31-32):1698-9; author reply 1699-70. PubMed ID: 15273924
    [No Abstract]   [Full Text] [Related]  

  • 11. Purification of protein C a natural anticoagulant, from human plasma by affinity chromatography with Convanavalin A.
    Pérez-Campos E; Córdoba F; Pérez-Ortega E; Martínez M; Zenteno E
    Prep Biochem Biotechnol; 1996; 26(3-4):183-8. PubMed ID: 8958567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous removal of T and B cell epitope in recombinant staphylokinase by structure-based mutagenesis of immuno-dominant Arg77 and Glu80 residues.
    Xu R; He J; Jia K; Chen X; Liu J; Zhu K
    Wei Sheng Wu Xue Bao; 2011 May; 51(5):692-703. PubMed ID: 21800633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated protein C for severe sepsis.
    Garces K
    Issues Emerg Health Technol; 2002 Mar; (30):1-4. PubMed ID: 11985365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated protein C: cost-effective or costly?
    Brar SS; Manns BJ
    Crit Care; 2007; 11(5):164. PubMed ID: 17875223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drotrecogin alfa: a role in emergency department treatment of severe sepsis?
    McLeay AM
    Emerg Med Australas; 2004 Aug; 16(4):324-35. PubMed ID: 15283720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Isolation, purification, and separation of the complex preparation of extracellular proteinases with fibrinolytic and anticoagulant properties from Aspergillus ochraceus 513].
    Batomunkueva BP; Egorov NS
    Mikrobiologiia; 2001; 70(5):602-6. PubMed ID: 11763777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cost-effectiveness analysis of aspirin versus oral anticoagulants after acute myocardial infarction in Italy -- equivalence of costs as a possible case for oral anticoagulants.
    Gianetti J; Gensini G; De Caterina R
    Thromb Haemost; 1998 Dec; 80(6):887-93. PubMed ID: 9869155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulant blood factor deficiencies (protein C).
    Bruley DF
    Adv Exp Med Biol; 2007; 599():1-6. PubMed ID: 17727240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-level expression of a heterologous protein in the milk of transgenic swine using the cDNA encoding human protein C.
    Velander WH; Johnson JL; Page RL; Russell CG; Subramanian A; Wilkins TD; Gwazdauskas FC; Pittius C; Drohan WN
    Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12003-7. PubMed ID: 1465430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to recombinant fragment 212-276 of protein C specifically recognize the intact human molecule.
    Fijalkowska I; Babinska A; Ligocka A; Plucienniczak G; Plucienniczak A; Stec W; Okruszek A; Wilk A; Cierniewski CS
    Biochim Biophys Acta; 1993 Feb; 1161(2-3):187-93. PubMed ID: 8431468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.